[Treatment of patients with different degree of acute respiratory distress syndrome caused by inhalation of white smoke]

Zhonghua Shao Shang Za Zhi. 2017 Dec 20;33(12):760-765. doi: 10.3760/cma.j.issn.1009-2587.2017.12.008.
[Article in Chinese]

Abstract

Objective: To summarize the treatment experience of patients with different degree of acute respiratory distress syndrome (ARDS) caused by inhalation of white smoke from burning smoke bomb. Methods: A batch of 13 patients with different degree of ARDS caused by inhalation of white smoke from burning smoke bomb, including 2 patients complicated by pulmonary fibrosis at the late stage, were admitted to our unit in February 2016. Patients were divided into mild (9 cases), moderate (2 cases), and serious (2 cases) degree according to the ARDS Berlin diagnostic criteria. Patients with mild and moderate ARDS were conventionally treated with glucocorticoid. Patients with severe ARDS were sequentially treated with glucocorticoid and pirfenidone, and ventilator-assisted breathing, etc. were applied. The vital signs, arterial oxygenation index, changes of lung imaging, pulmonary ventilation function, general condition, and the other important organs/systems function were timely monitored according to the condition of patients. The above indexes were also monitored during the follow-up time of 10-15 months post injury. Data were processed with SPSS 18.0 statistical software. Results: (1) The symptoms of respiratory system of patients with mild and moderate ARDS almost disappeared after 3 days' treatment. Their arterial oxygenation index was decreased from post injury day 1 to 4, which almost recovered on post injury day 7 and completely recovered one month post injury. The symptoms of respiratory system of patients with severe ARDS almost disappeared at tranquillization condition 1-3 month (s) post injury. Their arterial oxygenation index was decreased from post injury day 3 to 21, which gradually recovered 1-3 month (s) post injury and was normal 15 months post injury. (2) Within 24 hours post injury, there was no obvious abnormality or only a little texture enlargement of lung in image of chest CT or X-rays of patients with mild and moderate ARDS. One patient with moderate ARDS had diffuse patchy and ground-glass like increased density shadow (pulmonary exudation for short) at post injury hour 96. Chest iconography of all patients with mild and moderate ARDS showed no abnormalities 10 months post injury. Both lungs of each of the two patients with severe ARDS showed obvious pulmonary exudation at post injury hours 45 and 75, respectively. One patient with severe ARDS showed no abnormality in chest image 10 months post injury, but there was still a small mesh-like increased density shadow in double lobes with slight adhesion of pleura in the other patient with severe ARDS 15 months post injury. (3) All patients showed severe restrictive hypoventilation when admitted to hospital. Pulmonary ventilation function of patients with mild and moderate ARDS recovered to normal one month post injury, and they could do exercises like running, etc. Pulmonary ventilation function of one patient with severe ARDS recovered to normal 6 months post injury, and the patient could do exercises like running, etc. The other patient with severe ARDS showed mild restrictive hypoventilation 15 months post injury and could do exercises like rapid walking, etc. (4) The condition of all mild and one moderate ARDS patients was better on post injury day 3, and they were transferred to the local hospital for subsequent treatment and left hospital on post injury day 21. One patient with moderate ARDS healed and left hospital on post injury day 29. Patients with severe ARDS healed and left hospital on post injury day 81. During the follow-up time of 10-15 months post injury, the other important organs/systems of all patients showed no abnormality, and there was no adverse reaction of glucocorticoid like osteoporosis, femoral head necrosis, or metabolic disorder. Two patients with severe ARDS did not have any adverse reaction of pirfenidone like liver function damage, photosensitivity, anorexia, or lethargy. Conclusions: Early enough and uninterrupted application of glucocorticoid can significantly reduce the ARDS of patients caused by inhalation of white smoke from burning smoke bomb. Sequential application of glucocorticoid and pirfenidone can effectively treat pulmonary fibrosis at the late stage.

目的: 总结因吸入烟雾弹燃烧产生白烟致不同程度ARDS患者的救治经验。 方法: 2016年2月,笔者单位收治一批共13例因吸入烟雾弹燃烧产生的白烟引起不同程度ARDS患者,其中2例后期并发肺纤维化。参照ARDS柏林诊断标准,将患者分为轻度9例、中度2例、重度2例。轻、中度ARDS患者应用糖皮质激素常规治疗。重度ARDS患者序贯应用糖皮质激素、吡非尼酮治疗,行呼吸机辅助呼吸等。所有患者根据病情及时监测生命体征、动脉血氧合指数、肺部影像学变化、肺通气功能、一般情况及其他重要器官/系统功能等。伤后10~15个月随访,对上述指标进行监测。采用SPSS 18.0统计软件对数据进行统计。 结果: (1)轻、中度ARDS患者治疗3 d后呼吸系统症状基本消失;动脉血氧合指数伤后1~4 d降低,伤后7 d基本恢复正常,伤后1个月完全正常。重度ARDS患者伤后1~3个月呼吸系统症状静息情况下基本消失;动脉血氧合指数伤后3~21 d降低,伤后1~3个月逐渐恢复正常,伤后15个月复查正常。(2)轻、中度ARDS患者胸部CT或X线检查显示其伤后24 h内无明显异常或仅有肺纹理增粗。1例中度ARDS患者伤后96 h出现弥漫斑片状、磨玻璃样密度增高影(简称肺渗出影)。所有轻、中度ARDS患者伤后10个月复行胸部影像学检查,结果无异常。2例重度ARDS患者伤后45、75 h双肺出现明显肺渗出影,其中1例患者伤后10个月复行胸部影像学检查,结果无异常;1例患者伤后15个月复行胸部影像学检查,结果显示双肺叶内存留小范围网格样密度增高影,胸膜轻微粘连。(3)所有患者入院时肺功能检查提示重度限制性肺通气功能障碍。轻、中度ARDS患者肺通气功能于伤后1个月均恢复正常,能进行跑步等运动。1例重度ARDS患者肺通气功能于伤后6个月恢复正常,能进行跑步等运动;1例重度ARDS患者伤后15个月检查提示轻度限制性肺通气功能障碍,能适当进行快步行走等运动。(4)所有轻度以及1例中度ARDS患者于伤后第3天好转,转入当地医院继续治疗,伤后21 d治愈出院。1例中度ARDS患者于伤后29 d治愈出院;重度ARDS患者均于伤后81 d治愈出院。伤后10~15个月随访,所有患者其他重要器官/系统功能未见异常,也未见明显骨质疏松、股骨头坏死、代谢异常等糖皮质激素不良反应。2例重度ARDS患者未出现肝功能损害、光过敏、厌食、嗜睡等吡非尼酮不良反应。 结论: 早期足量不间断应用糖皮质激素可明显减轻患者吸入烟雾弹燃烧产生的白烟引起的ARDS,序贯应用糖皮质激素与吡非尼酮能有效治疗该类患者后期出现的肺纤维化。.

Keywords: Glucocorticoids; Pirfenidone; Pulmonary fibrosis; Respiratory distress syndrome, adult; Smoke bomb; White smoke.

MeSH terms

  • Blood Gas Analysis
  • Bombs
  • Humans
  • Lung
  • Male
  • Monitoring, Physiologic
  • Respiration, Artificial*
  • Respiratory Distress Syndrome / complications
  • Respiratory Distress Syndrome / therapy*
  • Smoke
  • Smoke Inhalation Injury / etiology*
  • Treatment Outcome

Substances

  • Smoke